Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Cash Flow
Glenmark Pharmaceuticals Ltd.
BSE Code 532296
ISIN Demat INE935A01035
Book Value (Rs) 868.32
NSE Code GLENMARK
Dividend Yield % 0.11
Market Cap(Rs Mn) 615635.17
TTM PE(x) 38.23
TTM EPS(Rs) 57.06
Face Value (Rs) 1  
Type:
(Rs. in Million)
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax5691.878684.5114412.4613824.7510960.76
Adjustment10098.1414719.637871.086448.186362.28
Changes In working Capital-7969.53-10744.81-5612.61-3858.381270.64
Cash Flow after changes in Working Capital7820.4812659.3316670.9316414.5518593.68
Cash Flow from Operating Activities-2654.446253.9211086.5211312.1313924.13
Cash Flow from Investing Activities45608.93-5284.91-3332.80-6752.36-7835.17
Cash Flow from Financing Activities-39061.27-774.56-5204.91-4417.79-4446.63
Net Cash Inflow / Outflow3893.22194.452548.81141.981642.33
Opening Cash & Cash Equivalents14430.2614105.2611380.9511102.759362.78
Cash & Cash Equivalent on Amalgamation / Take over / Merger06.68000
Cash & Cash Equivalent of Subsidiaries under liquidations-1917.570000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations176.79123.87175.50136.2297.64
Closing Cash & Cash Equivalent16582.7014430.2614105.2611380.9511102.75